Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Novel infusion strategy reduces severe adverse events caused by the anti-GD2 monoclonal antibody naxitamab.
Front Oncol. 2023 May 5;13:1164949. doi: 10.3389/fonc.2023.1164949. eCollection 2023.
Front Oncol. 2023.
PMID: 37213300
Free PMC article.
Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chance for Long-Term Outcomes.
Muñoz JP, Larrosa C, Chamorro S, Perez-Jaume S, Simao M, Sanchez-Sierra N, Varo A, Gorostegui M, Castañeda A, Garraus M, Lopez-Miralles S, Mora J.
Muñoz JP, et al. Among authors: chamorro s.
Cancers (Basel). 2023 Oct 3;15(19):4837. doi: 10.3390/cancers15194837.
Cancers (Basel). 2023.
PMID: 37835531
Free PMC article.
Item in Clipboard
Cite
Cite